BioGend Therapeutics Co (ROCO:6733) Change In Inventory : NT$-3.8 Mil (TTM As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is BioGend Therapeutics Co Change In Inventory?

BioGend Therapeutics Co's change in inventory for the quarter that ended in Mar. 2024 was NT$0.7 Mil. It means BioGend Therapeutics Co's inventory declined by NT$0.7 Mil from Dec. 2023 to Mar. 2024 .

BioGend Therapeutics Co's change in inventory for the fiscal year that ended in Dec. 2023 was NT$-11.6 Mil. It means BioGend Therapeutics Co's inventory increased by NT$11.6 Mil from Dec. 2022 to Dec. 2023 .

BioGend Therapeutics Co's Total Inventories for the quarter that ended in Mar. 2024 was NT$15.8 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. BioGend Therapeutics Co's Days Inventory for the quarter that ended in Mar. 2024 was 235.94.

Inventory Turnover measures how fast the company turns over its inventory within a year. BioGend Therapeutics Co's Inventory Turnover for the quarter that ended in Mar. 2024 was 0.39.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. BioGend Therapeutics Co's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 0.45.

BioGend Therapeutics Co Change In Inventory Historical Data

The historical data trend for BioGend Therapeutics Co's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioGend Therapeutics Co Change In Inventory Chart

BioGend Therapeutics Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Get a 7-Day Free Trial

-1.20

-7.90

1.38

4.13

-11.65

BioGend Therapeutics Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Inventory	Get a 7-Day Free Trial															-7.10	-4.29	1.40	-1.65	0.74

BioGend Therapeutics Co Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-3.8 Mil.

BioGend Therapeutics Co (ROCO:6733) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

BioGend Therapeutics Co's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	16.1735	/	6.255	*	365 / 4
	=	235.94

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

BioGend Therapeutics Co's Inventory Turnover for the quarter that ended in Mar. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	6.255	/	16.1735
	=	0.39

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

BioGend Therapeutics Co's Inventory to Revenue for the quarter that ended in Mar. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	16.1735	/	35.553
	=	0.45

BioGend Therapeutics Co Change In Inventory Related Terms

Thank you for viewing the detailed overview of BioGend Therapeutics Co's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

BioGend Therapeutics Co (ROCO:6733) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioGend Therapeutics Co Ltd (ROCO:6733) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

4th Floor, Number 3, Park Street, Nangang District, Taipei, TWN, 115

Website

https://www.biogend.com.tw

BioGend Therapeutics Co Ltd is a Taiwan based company involved in developing regenerative bio-orthopaedic medicine to advance the clinical science of maintaining healthy joints in skeletal system. The Company is primarily engaged in the research and development of bone medical device related products. Its products under development include Big-001, Big-006 and Big-009.

BioGend Therapeutics Co (ROCO:6733) Headlines

No Headlines